Association of Interleukin 6 with Positive Immunohistochemical staining of Estrogen Receptor in Breast Cancer Patients.

Main Article Content

Dalya Basil Hana

Abstract

The objective of this study is the evaluation of concentration levels of interleukin-6 (IL-6) in breast cancer patients and it's relation to estrogen receptor
(ER) expression on tumor cells. The expression of IL-6 and estrogen receptor , were studied on 30 patients (positive breast cancer ) and 30 controls (negative
breast cancer).Serum of studied groups were examined using Enzyme Linked Immuno-Sorbent Assay (ELISA) for IL-6 and breast biopsy specimens were
examined using immunohistochemical staining for estrogen receptor. The serum level of IL-6 was significantly higher in patients with breast cancer compared
with control (p<0.05). The number of positive ER expression in patients with breast cancer was higher than the negative expression (p<0.05). The current study found a positive significant correlation (r = 249; P<0.05) between serum levels of IL-6 and estrogen receptors (ER). The results of this study suggest that elevated IL-6 serum concentration are associated with breast cancer and found that high levels of IL-6 in breast cancer patients are associated with positive
estrogen receptor.

Article Details

Section

Articles

How to Cite

Association of Interleukin 6 with Positive Immunohistochemical staining of Estrogen Receptor in Breast Cancer Patients. (2010). Al Mustansiriyah Journal of Pharmaceutical Sciences, 7(1), 106-114. https://doi.org/10.32947/ajps.v7i1.322